The NLRP3/NALP3 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-043928 |
|---|
| Réf. fabricant | 18260216 |
|---|
| Gene ID (Entrez) | 114548 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | diH2O |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-77080. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1 |
|---|
| Symbole de gène(s) | NLRP3 |
|---|
| Type de produit | NLRP3/NALP3 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Catégorie de recherche | Alzheimers Research, Apoptosis, Cancer, Cardiovascular Biology, Cytokine Research, Immunology, Inflammation, Neurodegeneration, Signal Transduction |
|---|
| Consigne | 16 amino acids near the amino terminus of human of NALP3 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
